Feasibility and Pilot Validation of the ADHD Child Evaluation (ACEv.2) Clinical Interview.

Ivesa (firmonertinib) - Allist, ArriVent

http://www.ncbi.nlm.nih.gov/pubmed/42702878

Csenge Dajka; Gyöngyvér Ferenczi-Dallos; Judit Balazs; Lea Kiss-Sinka; Susan Young; Tímea Torzsa

Sep 8, 2026